On October 14, 2011, District Court Judge Paul A. Crotty denied The Mathilda and Terence Kennedy Institute of Rheumatology Trust’s motion to dismiss a suit brought by Abbott Laboratories seeking to invalidate a patent allegedly covering Abbott’s blockbuster arthritis drug Humira®. Abbott Laboratories is represented by Finnegan in this matter.